Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00466570
Status:
WITHDRAWN
Last Update Posted:
2013-06-13
First Post:
2007-04-25
Brief Title:
Prospective Randomized Comparison of ZymarGatifloxacin and Vigamox Moxifloxacin in Killing Conjunctival Bacterial Flora Following a One-hour Application
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
Prospective Randomized Comparison of ZymarGatifloxacin and Vigamox Moxifloxacin in Killing Conjunctival Bacterial Flora Following a One-hour
Status:
WITHDRAWN
Status Verified Date:
2013-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Topical ophthalmic antibiotics are common prescribed just prior to eye surgery to lower the risk of infection Previous studies have suggested that antibiotics containing a preservative Zymar kill bacteria much quicker than those without a preservative Vigamox The purpose of this research is to compare how quickly to the two commonly prescribed antibiotics eliminate bacteria from the eye surface
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None